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ABSTRACT 
In vivo fertilized embryos were surgi- 
cally collected from superovulated dairy 
cows to evaluate microinjection on 
embryo development and utilized the 
polymerase chain reaction technique 
for selection of transgenic embryos. 
Seventy-two percent of the embryos with 
visible pronuclei or nuclei were microin- 
jected with DNA, and the remaining 
28% served as uninjected controls. All 
embryos were cocultured with bovine 
oviductal epithelial cells. Mean final de- 
velopment scores of embryos within the 
same initial cell stage at collection were 
unaffected by microinjection. After 144 
h of culture, 45% of the microinjected 
embryos developed to the morula or 
blastocyst stage. The transgene was de- 
tected in 50, 10, and 9% of demimorulae 
from embryos microinjected at the 
1-, 2-, and 4-cell stages. Frequency of 
transgene detection was higher in moru- 
lae from 1-cell embryos than in morulae 
from 2- and 4-cell embryos. Use of in 
vitro coculture, embryo bisection, and 
polymerase chain reaction technique 
facilitated selection of bovine embryos 
that carried the transgene. 
(Key words: deoxyribonucleic acid 
microinjection, bovine embryo culture) 
Abbreviation key: OEC = oviductal epithelial 
cells, PCR = polymerase chain reaction. 
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INTRODUCTION 
Several investigators (5. 6, 23) interested in 
production of therapeutic human proteins in 
genetically engineered domestic animals have 
chosen the lactating mammary gland for trans- 
gene expression. Genes coding for therapeutic 
proteins have been successfully integrated and 
expressed in mammary glands of sheep (5,  23), 
goats (6), and pigs (21). Although milk produc- 
tion from these animals is copious, that of the 
dairy cow is superior; thus, the cow is an 
excellent choice for large-scale production of 
foreign proteins in the mammary gland. 
Production of transgenic dairy cattle by 
pronuclear microinjection has been hampered 
by a need for large numbers of embryo 
recipients (13), increased embryo mortality rate 
following microinjection (12, 16), and low fre- 
quencies of transgene integration and expres- 
sion (1, 13, 16). Efforts to reduce the number 
of embryo recipients required have included 
temporary placement of the microinjected em- 
bryos into rabbit, ovine, or bovine oviducts (1, 
9, 16) or culturing of the embryos in vitro (12) 
to facilitate selection of only those embryos 
that develop to the morula stage and to elimi- 
nate the need for surgical transfer of oviductal 
stage embryos. 
Increasing frequencies of transgene integra- 
tion might enhance production of transgenic 
cattle; however, current lack of information on 
mechanisms of transgene integration requires 
researchers to use other techniques to increase 
the number of transgenic calves born per trans- 
fer. Ninomiya et al. (14) used the polymerase 
chain reaction (PCR) technique (18) for detec- 
tion of a transgene in murine demimorulae 
produced from matings with transgenic males 
that carried two copies of the transgene. King 
and Wall (11) reported that a single-copy gene 
encoding the 6 chain of bovine LH could be 
detected in purified bovine genomic DNA 
representing 25 cells. We recently reported (19) 
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that either blastomere biopsy or embryo bisec- 
tion technique was suitable for cell recovery 
for DNA amplification. 
The objectives of this study were to evalu- 
ate the effect of DNA microinjection on bo- 
vine embryo development and to utilize in 
vitro culture, embryo bisection, and PCR to 
facilitate selection of transgenic bovine em- 
bryos for subsequent transfer. 
MATERIALS AND METHODS 
Superovulation 
Twenty-four reproductively healthy, nonlac- 
tating dairy cows were superovulated with 32 
mg of FSH (Schering Corp., Kenilworth, NJ) 
using a decreasing dose regimen over 4 con- 
secutive d initiated between d 9 and 13 of the 
estrous cycle. The PGF2, &utalyse@; Upjohn, 
Kalamazoo, MI) was administered 72 h (30 
mg) and 84 h (10 mg) after the initial FSH 
injection to induce luteal regression. Cattle 
displayed estrus 36 to 48 h after the first 
PGF2, injection and were bred by natural serv- 
ice at 0 h and by AI 12 and 24 h after the first 
observation of estrus. 
Island, NY) were flushed through the oviduct 
by introducing a 20-gauge blunt-ended needle 
into the uterine lumen 1 cm from the utero- 
tubal junction. The fluid was collected into 
sterile test tubes and transported to the labora- 
tory at 37°C. This procedure was repeated with 
the contralateral oviduct when it could be ex- 
teriorized through the same incision site. The 
reproductive tract was imgated with 3% (voY 
vol) glycerol in sterile saline to reduce adhe- 
sion formation before return to the abdominal 
cavity (2). When the distal ovary could not be 
exteriorized through the first incision site, the 
cow was rotated, and the entire procedure 
described was repeated to flush the remaining 
oviduct. 
Recovered fluid was searched for embryos 
and for oviductal epitheleal cells (OEC). The 
OEC were washed with tissue culture medium 
199 with Earle’s salts (Gibco) supplemented 
with 10% newborn calf serum (Gibco), pyru- 
vate (1 mg/ml), penicillin (1 mg/ml), and strep- 
tomycin (1 mg/ml) 4 to 6 times in a conical 
tube. After being washed, OEC were placed in 
2 5 ~ 1  drops of tissue culture medium 199 and 
10% newborn calf serum and maintained at 
39°C in an atmosphere of 5% C02 in air. 
Embryo Recovery Embryo Microinjection 
The 1- to 4-cell bovine embryos were surgi- 
cally collected 36 to 64 h after the first obser- 
vation of estrus. Oviducts were exteriorized via 
the caudal flank approach described by Wolfe 
et al. (22). Anesthesia was initiated with 
glycerol guaifenesin and thiopental and main- 
tained with halothane. After initiation of 
anesthesia, the cows were positioned in lateral 
recumbency. The rear limb of the exposed side 
was pulled caudally, and the flank of the same 
side was prepared and draped for aseptic sur- 
gery. 
The proximal ovary, oviduct, and uterine 
horn were exteriorized by gentle traction on 
the broad ligament. The number of ovulations 
and follicles was recorded. A polyethylene 
cannula (polyethylene tubing, i.d. 1.14 m, 
0.d. 1.57 mm; Intramedica; Clay Adams, Par- 
sippany, NJ) was threaded through the ostium 
of the infundibulum and 4 to 5 cm into the 
ampulla of the oviduct to facilitate fluid collec- 
tion. Approximately 20 to 30 ml of PBS (em- 
bryo transfer freezing medium; Gibco, Grand 
Recovered embryos were washed three 
times in PBS and transferred in 500 p1 of 
medium to sterile plastic vials for centrifuga- 
tion. Embryos were centrifuged at 16,000 x g 
for 6 min to facilitate visualization of 
pronuclei and nuclei. Following centrifugation, 
embryos were observed at 200x under Hoff- 
man modulation optics. Seventy-two percent of 
the embryos with visible nuclei or pronuclei 
were microinjected, and the remaining em- 
bryos were assigned to the control treatment. A 
greater proportion of embryos was assigned to 
the microinjection treatment to optimize the 
number of potentially transgenic embryos. 
To perform microinjection, the embryo was 
held by suction with a holding pipette (30 pm 
i.d.) controlled by one arm of the micro- 
manipulator. The other arm controlled the in- 
jection pipette, which was connected to an 
Eppendorf automatic microinjector (model 
5242; Eastern Microscopes, Raleigh, NC). The 
DNA used for microinjection was a 5.7-kb 
fragment consisting of the mouse whey acidic 
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protein promoter and 3’ elements with a human 
protein C cDNA inserted at the whey acidic 
protein coding region (4, 7, 21). The DNA was 
diluted in a buffer of 10 p M  Tris-HCI-1 and 8 
mM EDTA, pH 8.0, to make a final DNA 
concentration of 250 copies per picoliter. The 
most visible or largest pronucleus or nucleus 
was injected with 1 to 2 pl of the DNA solu- 
tion. One nucleus of each 2-cell embryo and 
two nuclei of 4-cell embryos were microin- 
jected to maintain consistency to allow for 
possible DNA integration into one-half of the 
genome. Visualization of swelling of the 
pronucleus or nucleus indicated a successful 
injection. 
Embryo Culture 
Microinjected embryos were cultured for 
approximately 144 h in 25-pl drops of tissue 
culture medium 199 and 10% newborn calf 
serum, pyruvate, penicillin, streptomycin, and 
OEC in an atmosphere of 5% C02 in air at 
39°C. Morphological stage of development 
was assessed 48 h after the initiation of cul- 
ture. All OEC and 4- and 8-cell embryos were 
washed after 48 h of culture and returned to 
tissue culture medium 199 supplemented with 
10% newborn calf serum, pyruvate, penicillin, 
and streptomycin. Morphological development 
was assessed at the termination of culture. 
Ampliflcation of the Transgene 
Microinjected embryos developing to the 
morula stage in culture were bisected to obtain 
cellular material for amplification of the trans- 
gene by PCR. Bisection occurred in a chamber 
consisting of a 100- x 15-mm sterile, plastic 
Petri dish lid that contained a 100-pl 
microdrop of PBS covered with silicone oil. A 
microsurgical blade (Special Blade S; Storz, 
Heidelberg, Germany) was passed vertically 
through the zona pellucida and cell mass. One 
demi-embryo was transferred with <2 p1 of 
PBS to 5 pl of filtered-sterilized (.22 pM) 
deionized water in a sterile, 250-pl plastic vial. 
Vials were held at -86’C and thawed immedi- 
ately prior to FCR. 
The PCR was performed as described by 
Sa ik i  e t  a l .  (17) u s ing  p r imers  5 ’ -  
CTCCTGCAGTGTCACCCCGCAGT-3’ and 
S’CACCATGTTGCTCATGACCTCGCTG- 
3’, which are complementary to the human 
protein C gene. Primers were positioned at 5 14 
and 1143 of protein C beginning at the 5‘ end. 
The predicted size of the PCR product is 630 
bp. Demi-embryos were subjected to 40 cycles 
of PCR in a volume of 25 pl that contained 50 
mM KC1; 10 mM Tris @H 8.8); 1.5 mM 
MgC12; . l %  Triton X-100; .2 pA4 each 
2‘-deoxyadenosine 5’-triphosphate, 2’-deoxy- 
thymidine 5’-triphosphate, 2’-deoxycytidine 
5‘-triphosphate, and 2‘-deoxyguanosine 5’- 
triphosphate; .5 p M  of each oligonucleotide 
primer; and .625 units of Taq polymerase 
(Themus aquaticus; Promega, Madison, WI). 
The entire reaction mixture was overlaid with 
25 p1 of paraffin oil. Each cycle consisted of 
denaturation at 96°C for 15 s, annealing for 
120 s at 55T ,  and extension of primers for 30 
s at 77°C. The initial cycle had denatured DNA 
by heating of the samples to 96°C for 1 min. 
Reaction products were visualized by addition 
of 10 p1 of 6x loading dye (15% Ficoll@-400, 
.25 p1 bromophenol blue; Sigma Chemical 
Co., St. Louis, MO) to each tube and loading 
25 p1 of this mixture in a 1% agarose gel 
(SeaKem@; FMC BioProducts, Rockland, ME) 
containing .5 pg/ml of ethidium bromide. Am- 
plified DNA was subjected to electrophoresis 
in a base of 40 mM Tis ,  40 mM acetate, 2 mM 
EDTA, and .5 pg/ml of ethidium bromide for 1 
h at 50 V. Amplified PCR fragments were 
visualized by UV transillumination and pho- 
tography. 
The remaining demi-embryos were returned 
to the coculture system immediately after 
microsurgery. The DNA amplification and 
identification of samples containing the trans- 
gene via agarose gel electrophoresis was com- 
pleted approximately 7.5 h after microsurgery. 
Embryo Transfer 
Embryos identified as positive for the trans- 
gene were transferred to recipient heifers 
within 10 h after microsurgery. Heifers were 
synchronized with 35 mg of PGF2, 12 to 24 h 
after PGF2, was administered to the superovu- 
lated donor. 
Embryos were loaded into a .25-cc straw 
and transferred nonsurgically to the uterus with 
a .25-cc, 8.27-cm Cuozzo Gun (EmCal, San 
Diego, CA). Following transfer, heifers were 
observed for signs of repeat estrus, and preg- 
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nancies were confirmed by rectal palpation at 
approximately 35 d of gestation. 
Statistical Analysis 
Mean final development scores of embryos 
for each treatment were calculated, and analy- 
sis was performed by ANOVA. Initial cell 
stage and microinjection treatment were in- 
dependent variables in the model. Differences 
in percentage of embryos developing to the 
morula stage for microinjection, initial cell 
stage, and frequency of transgene detection 
were tested by chi-square analysis. 
RESULTS 
Twenty-two of the 24 superovulated cows 
had 18.5 f 3.9 @ k SE) corpora hemorrhagica 
with 14.9 f 2.7 embryos recovered. Two cows 
failed to ovulate prior to surgery. Embryo data 
from two cows that subsequently had only 
unfertilized ova were included in the embryo 
recovery estimate. Embryo recovery rate, de- 
termined by the total number of embryos re- 
covered and corpora hemorrhagica observed, 
was 80.4% (329 per 409). Of the 329 embryos 
recovered, 62 (19%) were at the 4-cell stage, 
57 (17%) were classified as 2-cell, 208 (63%) 
were 1-cell, and 2 (1%) were degenerate. Fifty- 
three of the 208 I-cell ova (25%) were classi- 
fied as unfertilized because of lack of visible 
pronuclei and failure to cleave in culture. No 
attempt was made to stain pronuclei in the 
uncleaved 1-cell ova. 
Stage of embryo development at recovery 
was affected by time between the first observa- 
tion of estrus and surgery (P e .01; Figure 1). 
Two donors collected at 48 and 46 h postestrus 
had only unfertilized ova and were not in- 
cluded in Figure 1. Ninety-four percent (123 
i 
Figure 1 .  Mean cell number in embryos collected 
between 36 and 63 h after first observation of estrus. = 
The mean cell number of embryos recovered; n = the 
number of cows collected at each time. 
embryos) of the 131 embryos collected at 44 to 
53 h after first observation of estrus were at 
the 1-cell stage; 6 embryos (5%) were at the 
2-cell stage, and 2 embryos (1%) were unferti- 
lized ova. The earliest recovery time for col- 
lection of fertilized 1-cell embryos was 36 h 
after first observation of estrus. When the in- 
terval between first observation of estrus and 
surgery was increased to 260 h, the recovered 
embryo population was primarily at the 
2- to 4-cell stages. 
A total of 105 1-cell, 49 2-cell, and 43 
4-cell embryos were microinjected with whey 
acidic protein-human protein C; 50 1-cell, 8 
2-cell, and 19 4-cell embryos remained unin- 
jected. Five (3%) 1-cell embryos were de- 
stroyed by DNA microinjection. The percent- 
age of embryos with at least one cleavage after 
the initial 48 h of culture and the percentage of 
embryos developing to the morula stage were 
unaffected by initial cell stage or microinjec- 
tion (P > .05; Table 1). 
The mean final development score of em- 
bryos that cleaved at least once in culture was 
TABLE 1. Development of I-, 2-, and 4-cell injected and uninjected embryos cultured in vitro. 
Initial Cleaved 
n cell stage Treatment after 48 h 
Developing 
to morula 
(n) (%) (n) (%) 
2 Injected 49 45 92 18 37 
1 Injected 100 88 88 42 42 
Uninjected 50 50 100 15 30 
Uninjected 8 8 100 5 63 
4 Injected 43 35 81 27 63 
Uninjected 19 19 100 8 42 
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affected (P e .05) by the initial cell stage at 
recovery and the microinjection by initial cell 
stage at recovery interaction (Table 2). Unin- 
jected 4- and 2-cell embryos had higher (P < 
.05) mean development scores than did unin- 
jected 1-cell embryos, but mean development 
scores for injected 4- and 2-cell embryos did 
not differ from that of injected 1-cell embryos. 
Mean development scores for injected 1-, 
2-, and 4-cell embryos were not different (P > 
.OS) from those of uninjected 1-, 2-, and 
4-cell embryos. 
A total of 87 microinjected 1-, 2-, and 
4-cell embryos developed to the morula stage. 
Sixty-five morulae (75%) were considered to 
be acceptable for bisection (Table 3). Morulae 
that had numerous blastomeres that degener- 
ated or failed to compact were considered to be 
unacceptable for bisection. Frequency of trans- 
gene detection was greater (P < .01) in morulae 
that developed from embryos microinjected at 
the 1-cell stage than from embryos microin- 
jected at the 2- and 4-cell stages. 
Thirteen of the 19 demi-embryos containing 
whey acidic protein-human protein C were 
transferred to six synchronized recipients. 
Three recipients returned to estrus with no 
evidence of an extended estrous cycle. One 
recipient had a 28-d estrous cycle. A mem- 
branous sac was expelled from one recipient 
36 d after embryo transfer; the whey acidic 
protein-human protein C gene was detected in 
DNA extracted from the recovered membrane. 
The remaining recipient was confirmed preg- 
nant 45 d after embryo transfer but was ob- 
served to be in estrus 51 d posttransfer. The 
fetus was not recovered from this recipient. 
DISCUSSION 
The recovery of 2- and 4-cell embryos dur- 
ing collection of in vivo fertilized 1-cell em- 
bryos represents one of the many problems 
encountered in attempts to produce transgenic 
cattle by pronuclear DNA injection. Brinster et 
al. (3) reported that pronuclear microinjection 
produced transgenic mice more efficiently than 
DNA microinjection into nuclei of more ad- 
vanced embryos. These results have caused 
researchers to enhance production of bovine 
1-cell embryos by determination of the optimal 
time between estrus and collection (13, 16) or 
by production of 1-cell embryos by in vitro 
fertilization (13). Embryo recovery between 44 
and 53 h after the onset of estrus was optimal 
for collection of 1-cell fertilized embryos 
(Figure 1). Collection at 36 to 48 h postestrus 
in an earlier study (20) yielded a higher propor- 
tion of unfertilized ova (50%) than in the pres- 
ent study (17%). 
The percentage of microinjected 1-, 2-, and 
4-cell bovine embryos developing to the mor- 
ula stage in vitro was unaffected by initial cell 
stage (Table 1). Hawk et al. (9) reported that 
55% of 120 bovine microinjected embryos re- 
covered from rabbit oviducts had developed to 
the morula stage. The proportion of micro- 
injected 1-cell embryos developing to the mor- 
ula stage in vitro (42%) was comparable with 
the results of Hawk et al. (9) and higher than 
the 21% of microinjected 1-cell embryos de- 
veloping to the morula stage in the sheep 
oviduct reported by Biery et al. (1). 
The proportion of 1-, 2-, and 4-cell embryos 
developing to the morula stage in vitro was 
unaffected by microinjection (Table 1). Hawk 
et al. (9) reported similar results with in vivo 
TABLE 2. Least squares mean final development scores for injected and uninjected I - ,  2-. and 4-cell embryos cleaving at 
least once in vitro. 
Final development score' Initial 
cell 
stage Injected Uninjected All - - - 
X SE (n) X SE (n) X SE (n) 
1 5.1 .2ab 88 4.4 .3b 50 4.8 .2a 138 
2 4.6 .3b 45 5.9 .6a 8 5.2 .3ab 53 
4 5.6 .3a 35 5.6 .4a 19 5.6 .2b 54 
a,bDevelopment scores with different superscripts within the same column differ (P < ,051. 
lDevelopment was scored as 1 = 1-cell, 2 = 2-cel1, 3 = 4-cel1, 4 = 8-cel1, 5 = 16-cel1, 6 = morula, 7 = early blastocyst, 
8 = blastocyst, and 9 = expanded blastocyst. 
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TABLE 3. Transgene detection in demimorulae derived from microinjected I - ,  2-, and 4-cell bovine embryos 
Initial Developing Morulae 
cell to acceptable Transgene 
stage morula for bisection detection 
00 (n) (%I (n) (%) 
1 42 32 76 16 5oa 
2 18 IO 56 1 1 Ob 
4 27 23 85 2 9b 
Total 87 65 75 19 29 
aWhi-square (P < .01) between initial cell stages. 
fertilized, microinjected bovine embryos cul- 
tured in rabbit oviducts. In contrast, culture of 
in vitro fertilized, microinjected bovine em- 
bryos decreased the percentage of embryos 
developing to the morula stage following 
microinjection (8, 12). The results in this report 
and those of Hawk et al. (9) and Hill et al. (10) 
suggest that embryos fertilized in vivo are 
better candidates for DNA microinjection and 
culture than are embryos fertilized in vitro. 
Mean final development score of the 
I-,  2-,  and 4-cell bovine embryos was un- 
affected by microinjection but differed among 
initial cell stages (Table 2). Mean final de- 
velopment score for all 4-cell embryos was 
higher than for 1-cell embryos but was not 
different from 2-cell embryos. However, 
microinjected 1- and 4-cell embryos had simi- 
lar mean final development scores. These 
results are contrary to those of an earlier study 
by Brinster et al. (3), in which microinjection 
of 1- and 2-cell mouse embryos led to lower 
postmicroinjection survival rates and integra- 
tion for the embryos injected at the 2-cell 
stage. Data presented by Purse1 et al. (15) and 
in our study suggest that developmentally ad- 
vanced livestock embryos (>l-cell) are more 
resilient to microinjection than advanced 
mouse embryos. 
Sixty-five morulae (75%) of the 87 morulae 
that developed from microinjected 1-, 2-, and 
4-cell embryos were considered to be accepta- 
ble for bisection (Table 3). Transgene detection 
rate was higher in morulae that developed 
from embryos injected at the 1-cell stage (16 of 
32) than from embryos injected at the 2-cell (1 
of 10) or 4-cell (2  of 23) stages. Microinjection 
and subsequent analysis of half of the cells in 
the 2- and 4-cell embryos may have reduced 
transgene detection in morulae developing 
from embryos microinjected at the 2- and 
4-cell stages. We are not aware of any other 
studies that have evaluated gene integration 
rates in embryos that developed from bovine 
embryos microinjected at different cell stages. 
Comparable percentages of microinjected 
I-, 2-, and 4-cell embryos developed to the 
morula stage in vitro. Frequency of transgene 
detection was higher in morulae that developed 
from microinjected 1-cell embryos. These 
results indicate that the pronucleus is the pre- 
ferred target for DNA microinjection. 
Although low numbers of transferable 
transgene-positive demi-embryos did not allow 
establishment of pregnancy status, the combi- 
nation of in vitro culture, embryo bisection, 
and DNA amplification by PCR can be utilized 
for selection of potentially positive transgenic 
bovine embryos for nonsurgical transfer to 
synchronized recipients. 
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